2 key stock picks for reliable passive income

I’m looking at stocks that can deliver reliable passive income to complement my growth picks, and I think I’ve found them.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A couple celebrating moving in to a new home

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

As an investor who is primarily focused on growth and disruption, picking solid and reliable passive income stocks can seem somewhat underwhelming. That is why it is important to remember that when we talk about passive income stocks, we are talking about companies that deliver a dividend purely by virtue of owning them. This is a powerful selling point for an investor, even for growth-focused investors like myself, as the income received can also be reinvested.

It’s worth noting that high dividend yields don’t automatically mean superiority, as we are looking for reliable passive income that can be reinvested — and too high of a yield can be considered a risk to long-term company prospects.

Phoenix Group Holdings

My first pick is insurance and savings giant Phoenix Group Holdings (LSE:PHNX).

Like much of the market, Phoenix’s share price has come under selling pressure since its peaks in 2021 and, despite a strong start to the year, is currently trading at 628p, 17% off its 52-week high.

Even taking into account the current volatility in the market, this drop looks overdone, with Phoenix once again declaring annual growth in free cash flow, new business and profitability.

Phoenix Group boasts an impressive track record of stable growth in both profitability and dividends, providing shareholders with a whopping 8% dividend yield. This meant the company boosted its investors’ coffers with 3% organic dividend growth on the year, and keeps it in line with the sustainable 4% compound annual growth rate (CAGR) in dividends it has provided shareholders since 2011.

My one concern here would be the maturity of the underlying businesses owned by Phoenix and whether such levels of growth can be maintained under stricter market conditions. That being said, Phoenix has a rich history of smart strategic acquisitions, and so I certainly wouldn’t bet against its ability to maintain this level of income over the coming years.

GlaxoSmithKline

Next up, a potentially surprising choice, in GlaxoSmithKline (LSE:GSK), currently trading at 1,771p.

A £90bn-cap pharma giant wouldn’t normally be considered a surprise pick, but growth in revenue for Glaxo has been relatively slow, and it has not raised dividends since 2014, keeping the yield at a steady 4.5%. Nonetheless, that is still well above the current FTSE 100 average yield of 3.3%.

Glaxo also had a strong first quarter with revenue and net income increasing by 32% and 68% year on year respectively. This has been reflected somewhat in performance with its share price demonstrating considerable relative strength in the face of a protracted sector pullback.

Moreover, the company operates in a sector that tends to outperform both going in and coming out of recession cycles which goes some way to offsetting growing pains.

Given the pressure the biotech sector has come under, coupled with GlaxoSmithKline’s cash position, there also appears to be some attractive merger and acquisition possibilities to shore up its pipeline. Overall, GSK will be a key pick for my passive income portfolio going forward.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Joshua Kalinsky has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

With a 30% increase since the start of the year, does the Barclays share price still offer good value?

In light of an impressive Barclays share price rally, our writer considers the attractiveness of the bank’s stock relative to…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

How much passive income could we earn from UK shares with just £10 per day?

Even with modest amounts of money to invest, we can still consider investing in the UK stock market to generate…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

3 booming growth shares in the Scottish Mortgage portfolio

Our writer highlights a diverse trio of red-hot shares from the portfolio of Scottish Mortgage Investment Trust. Are any worth…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

2 growth stocks absolutely smashing the FTSE 100

If you think the wider FTSE 100 is having a good year (and it is), check out the gains holders…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

FTSE 100: next stop 10,000?

As the FTSE 100 briefly hits 9,000 points, investors are already looking forward to when the next 1,000-point level might…

Read more »

Investing Articles

Is Burberry ‘back’ as a solid update drives its shares to 17-month highs?

Burberry shares have risen by more than 60% since May's forecast-beating financials. Can the FTSE 250 luxury giant keep rising?

Read more »

Two gay men are walking through a Victorian shopping arcade
Investing Articles

The Burberry share price continues to rise despite falling sales!

Our writer looks at how the Burberry share price responded to the company’s first-quarter trading update, which was released earlier…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

What a crazy day for the share price of this FTSE 250 retailer!

Our writer’s taken time to digest the latest results of the FTSE 250’s Frasers Group. And he likes what he…

Read more »